Enzymatic and molecular diagnosis of Gaucher disease.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Clinics in Laboratory Medicine

• Publication date

  1995-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0272-2712(18)30306-8PMID 8838229
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gaucher disease: The effects of phosphatidylserine on glucocerebrosidase from normal and Gaucher fibroblasts

  2004cited by this paper
• A new diagnostic test for Gaucher disease suitable for population screening.

  1994cited by this paper
• Transduction of CD34+ enriched cord blood and Gaucher bone marrow cells by a retroviral vector carrying the glucocerebrosidase gene.

  1994cited by this paper
• DNA mutational analysis of type 1 and type 3 gaucher patients: How well do mutations predict phenotype?

  1994cited by this paper
• Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications.

  1993cited by this paper
• Clinical heterogeneity among patients with Gaucher's disease.

  1993cited by this paper
• Gaucher disease: gene frequencies in the Ashkenazi Jewish population.

  1993cited by this paper
• Gaucher disease: A G+1----A+1 IVS2 splice donor site mutation causing exon 2 skipping in the acid beta-glucosidase mRNA.

  1992cited by this paper
• DNA mutation analysis of Gaucher patients.

  1992cited by this paper
• Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state.

  1991cited by this paper
• Characterization of human glucocerebrosidase from different mutant alleles.

  1991cited by this paper
• Prediction of severity of Gaucher's disease by identification of mutations at DNA level.

  1989cited by this paper
• The human glucocerebrosidase gene and pseudogene: structure and evolution.

  1989cited by this paper
• Gaucher disease: molecular heterogeneity and phenotype-genotype correlations.

  1989cited by this paper
• Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals.

  1988cited by this paper
• Relationship between the two immunologically distinguishable forms of glucocerebrosidase in tissue extracts.

  1987cited by this paper
• A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease.

  1987cited by this paper
• Efficient In Vitro and In Vivo Expression of Human Glucocerebrosidase cDNA

  1987cited by this paper
• Human acid beta-glucosidase: Northern blot and S1 nuclease analysis of mRNA from HeLa cells and normal and Gaucher disease fibroblasts.

  1986cited by this paper
• Nucleotide sequence of cDNA containing the complete coding sequence for human lysosomal glucocerebrosidase.

  1986cited by this paper
• Deficient activity of glucocerebrosidase in urine from patients with type 1 Gaucher disease.

  1986cited by this paper
• Lysosomal enzymes in chorionic villi, cultured amniocytes, and cultured skin fibroblasts.

  1986cited by this paper
• A procedure for the rapid purification in high yield of human glucocerebrosidase using immunoaffinity chromatography with monoclonal antibodies.

  1986cited by this paper
• Gene mapping and leader polypeptide sequence of human glucocerebrosidase: implications for Gaucher disease.

  1985cited by this paper
• Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.

  1985cited by this paper
• Purification of beta-glucocerebrosidase by preparative-scale high-performance liquid chromatography: the use of ethylene glycol-containing buffers for chromatography of hydrophobic glycoprotein enzymes.

  1985cited by this paper
• Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA.

  1985cited by this paper
• Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients.

  1985cited by this paper
• Characterization of the phospholipid requirement of a rat liver beta-glucosidase.

  1984cited by this paper
• Isolation of cDNA clones for human beta-glucocerebrosidase using the lambda gt11 expression system.

  1984cited by this paper
• Calmodulin and parvalbumin: activators of human liver glucocerebrosidase.

  1984cited by this paper
• Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.

  1984cited by this paper
• An improved procedure for diagnosis of Gaucher disease using cultured skin fibroblasts and the chromogenic substrate, 2-hexadecanoylamino-4-nitrophenyl-beta-D-glucopyranoside.

  1982cited by this paper
• beta-Glucosidase assays in the diagnosis of Gaucher's disease.

  1982cited by this paper
• Gaucher type I (Ashkenazi) disease: a new method for heterozygote detection using a novel fluorescent natural substrate.

  1982cited by this paper
• Enzymic Differentiation of Neurologic and Nonneurologic Forms of Gaucher's Disease

  1982cited by this paper
• Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease.

  1980cited by this paper
• Enzymic diagnosis in 27 cases with Gaucher's disease.

  1980cited by this paper
• A modified method for the identification of heterozygotes for Gaucher's disease using differential thermal inactivation

  1980cited by this paper
• Activation of membrane-bound glucosylceramide: beta-glucosidase in fibroblasts cultured from normal and glucosylceramidotic human skin.

  1979cited by this paper
• Synthetic substrate beta-glucosidase activity in leukocytes: a reproducible method for the identification of patients and carriers of Gaucher's disease.

  1978cited by this paper
• Properties of beta-glucosidase in cultured skin fibroblasts from controls and patients with Gaucher disease.

  1978cited by this paper
• Enzyme replacement therapy in Gaucher's disease: large-scale purification of glucocerebrosidase suitable for human administration.

  1977cited by this paper
• Differentiation of beta-glucocerebrosidase from beta-glucosidase in human tissues using sodium taurocholate.

  1976cited by this paper
• Isolation and characterization of glucocerebrosidase from human placental tissue.

  1973cited by this paper
• Adult Gaucher's disease: kindred studies and demonstration of a deficiency of acid beta-glucosidase in cultured fibroblasts.

  1972cited by this paper
• Beta-glucosidase activity in fibroblasts from homozygotes and heterozygotes for Gaucher's disease.

  1971cited by this paper
• The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes.

  1970cited by this paper
• METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.

  1965cited by this paper

• Guía para diagnóstico y tratamiento de la Enfermedad de Gaucher Guidelines for diagnosis and treatment of Gaucher Disease

  2015cites this paper
• Clinical and genetic characteristics of Gaucher disease according to phenotypic subgroups

  2012cites this paper
• Bone manifestations of Gaucher’s disease in Mexican patients

  2011cites this paper
• Manifestaciones óseas en enfermedad de Gaucher entre pacientes mexicanos

  2010cites this paper
• Recommendations on diagnosis, treatment, and monitoring for Gaucher disease.

  2009cites this paper
• Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations.

  2004cites this paper
• Gaucher disease.

  2003cites this paper
• Mild thrombocytopenia as presenting symptom of type 1 Gauchers’s disease

  2001cites this paper
• Lessons learned from the development of enzyme therapy for Gaucher disease

  2001cites this paper
• Gaucher disease: recommendations on diagnosis, evaluation, and monitoring.

  1998cites this paper